GlassScriptPhysician profile
Shawn W Wells
NPI 1336706779
$2,589.37
in general payments reported to CMS, 2019-2025
17 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.00 · 2022: $155 · 2023: $944 · 2024: $994 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,363.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $620.80 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $483.09 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $338.13 | 2021-2025 | Mounjaro, Zepbound |
| Amgen INC. | $207.54 | 2021-2024 | Otezla, Repatha |
| Pfizer INC. | $187.99 | 2023-2025 | |
| Glaxosmithkline, LLC. | $132.62 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Axsome Therapeutics, INC. | $116.55 | 2025 | Auvelity |
| Abbott Laboratories | $85.80 | 2023-2024 | Freestyle Libre 3 |
| Exact Sciences Corporation | $65.94 | 2023-2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $65.54 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $60.66 | 2024 | |
| Medtronic, INC. | $55.88 | 2023-2025 | Intellis Adaptivestim, Closurefast |
| Globus Medical, INC. | $42.97 | 2025 | Senza |
| Dexcom, INC. | $38.35 | 2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $33.48 | 2023-2024 | Gardasil 9, Vaxneuvance, Gardasil |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $31.22 | 2025 | |
| Photonicare INC | $22.81 | 2025 | Otosight Middle Ear Scope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.